• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晶体基质蛋白与人类凝血酶原相关。

Crystal matrix protein is related to human prothrombin.

作者信息

Stapleton A M, Simpson R J, Ryall R L

机构信息

Department of Surgery, Flinders Medical Centre, Australia.

出版信息

Biochem Biophys Res Commun. 1993 Sep 30;195(3):1199-203. doi: 10.1006/bbrc.1993.2171.

DOI:10.1006/bbrc.1993.2171
PMID:8216249
Abstract

Crystal matrix protein (CMP) is the principal protein found in calcium oxalate (CaOx) crystals precipitated from whole human urine. It is a potent inhibitor of crystal aggregation and may therefore be important in the aetiology of kidney stone disease. CMP was isolated from CaOx crystals by EDTA dissolution and purified by Sephacryl S-200 column chromatography and reversed-phase high pressure liquid chromatography. Edman degradation revealed 81.8% sequence identity of the 11 N-terminal amino acids of CMP with the N-terminus of human prothrombin, which contains 10 gamma-carboxyglutamic acid residues in the first 32 amino acids. The apparent relationship between CMP and prothrombin was confirmed when an antibody to human prothrombin reacted with CMP upon Western blotting of sodium dodecyl sulphate polyacrylamide gels of the protein.

摘要

晶体基质蛋白(CMP)是从正常人尿液中沉淀出的草酸钙(CaOx)晶体中发现的主要蛋白质。它是晶体聚集的有效抑制剂,因此可能在肾结石疾病的病因学中起重要作用。通过EDTA溶解从CaOx晶体中分离出CMP,并通过Sephacryl S-200柱色谱法和反相高压液相色谱法进行纯化。埃德曼降解显示,CMP的11个N端氨基酸与人类凝血酶原的N端具有81.8%的序列同一性,后者在前32个氨基酸中含有10个γ-羧基谷氨酸残基。当用抗人凝血酶原抗体对该蛋白质的十二烷基硫酸钠聚丙烯酰胺凝胶进行蛋白质免疫印迹时,该抗体与CMP发生反应,从而证实了CMP与凝血酶原之间的明显关系。

相似文献

1
Crystal matrix protein is related to human prothrombin.晶体基质蛋白与人类凝血酶原相关。
Biochem Biophys Res Commun. 1993 Sep 30;195(3):1199-203. doi: 10.1006/bbrc.1993.2171.
2
Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin.
Urol Res. 1994;22(1):45-50. doi: 10.1007/BF00431548.
3
Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.晶内蛋白质与尿石症:一水草酸钙和二水草酸钙晶体蛋白质含量及超微结构的比较
BJU Int. 2005 Sep;96(4):654-63. doi: 10.1111/j.1464-410X.2005.05701.x.
4
[Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].富含糖醛酸的蛋白质:一种新型糖蛋白在体外抑制草酸钙结晶
Nephrologie. 1996;17(3):157-62.
5
Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.凝血酶原及其激活片段对体外未稀释人尿中草酸钙晶体生长和聚集的影响:蛋白质结构与抑制活性之间的关系。
Clin Sci (Lond). 2002 Apr;102(4):425-34.
6
Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.草酸钙肾结石中髓过氧化物酶、α-防御素和钙粒蛋白的鉴定。
Clin Chim Acta. 2007 Sep;384(1-2):41-7. doi: 10.1016/j.cca.2007.05.015. Epub 2007 May 26.
7
Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.富含尿酸的结石基质上草酸钙的外延沉积是由一种29 kDa的蛋白质诱导的。
Clin Chim Acta. 2006 Feb;364(1-2):267-74. doi: 10.1016/j.cca.2005.07.010. Epub 2005 Sep 1.
8
Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.尿凝血酶原片段1在草酸钙结石形成中的作用。
J Urol. 2005 Jan;173(1):113-6. doi: 10.1097/01.ju.0000146847.24571.c8.
9
The hole truth: intracrystalline proteins and calcium oxalate kidney stones.真相:晶内蛋白与草酸钙肾结石
Mol Urol. 2000 Winter;4(4):391-402.
10
Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
Br J Urol. 1995 Jun;75(6):712-9. doi: 10.1111/j.1464-410x.1995.tb07377.x.

引用本文的文献

1
Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation.草酸钙肾结石形成过程中尿蛋白机制的研究进展
Urolithiasis. 2025 Feb 11;53(1):27. doi: 10.1007/s00240-025-01703-6.
2
What does the crystallography of stones tell us about their formation?结石的晶体结构能告诉我们它们是如何形成的?
Urolithiasis. 2017 Feb;45(1):11-18. doi: 10.1007/s00240-016-0951-0. Epub 2016 Nov 29.
3
Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.肾结石:肾结石形成的分子机制和调节剂的关键作用。
Biomed Res Int. 2013;2013:292953. doi: 10.1155/2013/292953. Epub 2013 Sep 14.
4
Diversity in protein profiles of individual calcium oxalate kidney stones.个体草酸钙肾结石中蛋白质谱的多样性。
PLoS One. 2013 Jul 9;8(7):e68624. doi: 10.1371/journal.pone.0068624. Print 2013.
5
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.草酸钙结晶的尿中抑制剂及其在结石形成中的潜在作用。
World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852.
6
Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.正常人尿液和大鼠尿液中体外诱导产生的尿大分子与草酸钙晶体的关联。
Urol Res. 1996;24(1):45-50. doi: 10.1007/BF00296733.
7
Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.糖胺聚糖、蛋白质与结石形成:成人话题与儿童游戏
Pediatr Nephrol. 1996 Oct;10(5):656-66. doi: 10.1007/s004670050185.
8
Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro.草酸钙晶体基质提取物:在体外未稀释的人尿中测试过的最有效的晶体生长和聚集的大分子抑制剂。
Urol Res. 1995;23(1):53-62. doi: 10.1007/BF00298852.